ACRX SEC Form 4 filings

Acelrx Pharmaceuticals Inc Latest Insider Trading Activity

Over the past 2,831 days, Acelrx Pharmaceuticals Inc (ACRX) has had 10 total open-market insider transactions represented in the displayed records. The most recent transaction was on December 13, 2023, when Angotti Vincent J. (Acelrx Pharmaceuticals Inc Chief Executive Officer) reported a purchase of 10,000 shares at $0.73 per share. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.

Insider Trading For ACRX Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).

▲ Insider buy ▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
Ticker Filing Date Transaction Date Company Insider Title Transaction Trade Count Shares Avg. Price Total Value Position Size Change SEC Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. ACRX 2023-12-14 2023-12-13 Acelrx Pharmaceuticals Inc Angotti Vincent J. Chief Executive Officer Buy 1 10,000 $0.73 $7,300.00 9.82% View Filing
ESPP: Employee share purchase program ACRX 2023-09-11 2023-09-11 Acelrx Pharmaceuticals Inc Angotti Vincent J. Chief Executive Officer Buy 1 10,000 $0.80 $8,000.00 10.89% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. ACRX 2020-06-15 2020-06-15 Acelrx Pharmaceuticals Inc Adams Adrian Director Buy 1 100,000 $1.29 $129,000.00 55.94% View Filing
ESPP: Employee share purchase program ACRX 2020-06-15 2020-06-15 Acelrx Pharmaceuticals Inc Angotti Vincent J. Chief Executive Officer Buy 1 7,547 $1.33 $10,037.51 1.61% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. ACRX 2019-06-06 2019-06-05 Acelrx Pharmaceuticals Inc Angotti Vincent J. Chief Executive Officer Buy 1 5,000 $2.31 $11,550.00 1.90% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. ACRX 2019-03-12 2019-03-12 Acelrx Pharmaceuticals Inc Edwards Mark G Director Buy 1 19,000 $2.99 $56,810.00 9.50% View Filing
ESPP: Employee share purchase program ACRX 2019-03-04 2019-02-28 Acelrx Pharmaceuticals Inc Asadorian Raffi Chief Financial Officer Buy 1 3,647 $2.81 $10,248.07 2.93% View Filing
ESPP: Employee share purchase program ACRX 2019-03-04 2019-02-28 Acelrx Pharmaceuticals Inc Dasu Badri N Chief Engineering Officer Buy 1 9,206 $2.81 $25,868.86 8.13% View Filing
ESPP: Employee share purchase program ACRX 2019-03-04 2019-02-28 Acelrx Pharmaceuticals Inc Palmer Pamela P Chief Medical Officer Buy 1 840 $2.81 $2,360.40 0.16% View Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. ACRX 2018-12-17 2018-12-14 Acelrx Pharmaceuticals Inc Angotti Vincent J. Chief Executive Officer Buy 1 3,610 $2.78 $10,035.80 6.61% View Filing

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 3.00 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.